0001213900-17-008317.txt : 20170808 0001213900-17-008317.hdr.sgml : 20170808 20170808145100 ACCESSION NUMBER: 0001213900-17-008317 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170808 DATE AS OF CHANGE: 20170808 EFFECTIVENESS DATE: 20170808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd. CENTRAL INDEX KEY: 0001614744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-292337 FILM NUMBER: 171014361 BUSINESS ADDRESS: STREET 1: ONE AZRIELI CENTER STREET 2: ROUND TOWER, FLOOR 23 CITY: TEL AVIV STATE: L3 ZIP: 6701101 BUSINESS PHONE: 97239333121 MAIL ADDRESS: STREET 1: ONE AZRIELI CENTER STREET 2: ROUND TOWER, FLOOR 23 CITY: TEL AVIV STATE: L3 ZIP: 6701101 D 1 primary_doc.xml X0708 D LIVE 0001614744 Kitov Pharmaceuticals Holdings Ltd. ONE AZRIELI CENTER ROUND BUILDING TEL AVIV L3 ISRAEL 6701101 97239333121 ISRAEL Mainrom Line Logistics Ltd. None Other Limited company true Isaac Israel One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Executive Officer and Director of the Issuer John Paul Waymack One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Medical Officer and Chairman of the Board of Directors Simcha Rock One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Chief Financial Officer and Director Steven Steinberg One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director Ido Agmon One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director Arye Weber One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director Ran Tzror One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director Revital Stern-Raff One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Director Director Gil Ben-Menachem One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Director Vice President of Business Development Avraham Ben-Tzvi One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Group Chief Legal Officer Hadas Reuveni One Azrieli Center Round Building Tel Aviv L3 ISRAEL 6701101 Executive Officer Founder and Chief Technology Officer of TyrNovo Pharmaceuticals Decline to Disclose 06b false 2017-07-11 false true false 0 Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NJ NEW JERSEY NY NEW YORK false 1981005 1981005 0 Represents the aggregate amount received from investors in connection with Issuer's registered offering of ADSs and concurrent private placement of warrants, respectively, which were issued jointly to investors for a single purchase price. false 14 138670 0 Represents 6% commission and 1% management fee of gross proceeds from investors for sale of ADSs and warrants in the registered offering and concurrent private placement. We will also pay expenses up to $75,000 and issued an unregistered warrant. 0 false Kitov Pharmaceuticals Holdings Ltd. /s/ Simcha Rock Simcha Rock Chief Financial Officer and Director 2017-08-08